Payment Resources

1. Why The TrialKit Platform License Agreement Changes The Economics Of Clinical Trials 2/24/2026

   A platform‑based pricing model removes change‑order friction, enabling predictable budgets and faster study adjustments. It supports operational agility and portfolio‑level efficiency as trials evolve.

2. The Power Of Patient Preferences: Technology And Payment Automation 2/14/2025

   How can you leverage customizable, simplified payment methods and third-party providers to improve patient convenience in your clinical trial?

3. How To Budget For Site Payments Success 4/27/2023

   Unearth how bringing the functions of medical writing, clinical data management, and electronic data capture can positively impact the creation of a budget and payment process.

4. Navigating The Complexities Of Clinical Trial Site Payments Forecasting 7/9/2024

   Advanced technology and best practices have the potential to revolutionize clinical trial site payment forecasting, leading to significant improvements in overall trial efficiency and management.

5. From Nice-To-Have To Must-Have: The Importance Of Patient Convenience Solutions 7/11/2024

   Seasoned clinical research expert and advocate of data ethics Angela Radcliffe discusses how the industry can enhance the lives of both patients and clinical trial sites.

6. How Real-World Data On Site Costs Accelerates Clinical Trial Success 10/23/2025

   Outdated budgeting slows oncology trials. Real-world site cost data enables faster planning, smoother startup, and better patient care through smarter, evidence-based financial decisions.

7. Helping Biotechs Overcome 4 Key Challenges 3/10/2025

   Delays in site payments, participant reimbursements, and logistical inefficiencies can create roadblocks for patients and sites.

8. The Rise Of The Clinical Trial Site Mega Network 1/13/2025

   Learn about the evolving U.S. clinical trial site market landscape including a detailed analysis of ownership models, market segmentation, and the role of financial investors in acquisitions. 

9. From Policy To Practice: PBM Reform, TrumpRx, And Global Drug Development 3/4/2026

   Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.

10. Evidence Of An Industry's Readiness To Collaborate 11/13/2024

    The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients.